Original Source(s)
Related Content
FDA Flags Missing Trial Results
Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available
April 13, 2026
-
3 min
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min
Automated Staining Aids Real-Time Tumor Calls
Automated frozen-section staining helped classify selected ambiguous tumors and margins in a single-center validation study.
May 11, 2026
-
3 min